The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Open accessAbstract
Fibrosis occurs when there is an imbalance in extracellular matrix (ECM) deposition and degradation. Excessive ECM deposition results in scarring and thickening of the affected tissue, and interferes with tissue and organ homeostasis - mimicking an exaggerated "wound healing" response. Many transforming growth factor-β (TGF-β) ligands are potent drivers of ECM deposition, and additionally, have a natural affinity for the ECM, creating a concentrated pool of pro-fibrotic factors at the site of injury. Consequently, TGF-β ligands are upregulated in many human fibrotic conditions and, as such, are attractive targets for fibrosis therapy. Here, we will discuss the contribution of TGF-β proteins in the pathogenesis of fibrosis, and promising anti-fibrotic approaches that target TGF-β ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Presser, L., McRae, S., & Waris, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056367 · Cited by 79
RetractedTGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Dennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
Targeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix
Wipff, P.-J., Rifkin, D. B., Meister, J.-J., & Hinz, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704042 · Cited by 1,346
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81460-9 · Cited by 1,174
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.
Lyons, R. M., Gentry, L. E., Purchio, A. F., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.1361 · Cited by 737
Hocevar, B. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1345 · Cited by 675
Verrecchia, F., Chu, M.-L., & Mauviel, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100754200 · Cited by 664
Two major Smad pathways in TGF‐β superfamily signalling
Miyazawa, K., Shinozaki, M., Hara, T., Furuya, T., & Miyazono, K. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00599.x · Cited by 662
Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing
Margadant, C., & Sonnenberg, A. (2010) · The EMBO Reports · doi:10.1038/embor.2009.276 · Cited by 653 · cited 1×
“…(PAI-1; Dennler et al., 1998; Hua et al., 1998), various proteoglycans (Schonherr et al., 1991; Romaris et al., 1995; Dadlani et al., 2008), integrins (Margadant and Sonnenberg, 2010), connective tissue growth factor (Chen et al., 2002), and matrix metalloproteases (MMPs; Yuan and Varga, 2001).”
BackgroundLoss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema
Morris, D. G., Huang, X., Kaminski, N., Wang, Y., Shapiro, S. D., Dolganov, G., Glick, A., & Sheppard, D. (2003) · Nature · doi:10.1038/nature01413 · Cited by 500
Vaughan, M. B., Howard, E. W., & Tomasek, J. J. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4869 · Cited by 476
Fan, J.-M., Ng, Y.-Y., Hill, P. A., Nikolic-Paterson, D. J., Mu, W., Atkins, R. C., & Lan, H. Y. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00656.x · Cited by 471
Induction of Cardiac Fibrosis by Transforming Growth Factor-β1
Lijnen, P. J., Petrov, V. V., & Fagard, R. H. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3032 · Cited by 464
Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure
Wahl, S. M. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918135 · Cited by 407
Sharma, M., Kambadur, R., Matthews, K. G., Somers, W. G., Devlin, G. P., Conaglen, J. V., Fowke, P. J., & Bass, J. J. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199907)180:1<1::aid-jcp1>3.0.co;2-v · Cited by 404
Schönherr, E., Järveläinen, H. T., Sandell, L. J., & Wight, T. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47419-x · Cited by 334
Wakefield, L. M., Winokur, T. S., Hollands, R. S., Christopherson, K., Levinson, A. D., & Sporn, M. B. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114932 · Cited by 319
Ferguson, M. W., Duncan, J., Bond, J., Bush, J., Durani, P., So, K., Taylor, L., Chantrey, J., Mason, T., James, G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60322-6 · Cited by 292
Hua, X., Liu, X., Ansari, D. O., & Lodish, H. F. (1998) · Genes & Development · doi:10.1101/gad.12.19.3084 · Cited by 283
Thrombospondin-1: Multiple Paths to Inflammation
Lopez-Dee, Z., Pidcock, K., & Gutierrez, L. S. (2011) · Mediators of Inflammation · doi:10.1155/2011/296069 · Cited by 283
Clouthier, D. E., Comerford, S. A., & Hammer, R. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119815 · Cited by 282
Yuan, W., & Varga, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107081200 · Cited by 275
Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
Voelker, J., Berg, P. H., Sheetz, M., Duffin, K., Shen, T., Moser, B., Greene, T., Blumenthal, S. S., Rychlik, I., Yagil, Y., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111230 · Cited by 275
Milani, S., Herbst, H., Schuppan, D., Stein, H., & Surrenti, C. (1991) · PubMed · Cited by 267
Myostatin Directly Regulates Skeletal Muscle Fibrosis
Li, Z. B., Kollias, H. D., & Wagner, K. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802585200 · Cited by 262
Li, J., Qu, X., Yao, J., Caruana, G., Ricardo, S. D., Yamamoto, Y., Yamamoto, H., & Bertram, J. F. (2010) · Diabetes · doi:10.2337/db09-1631 · Cited by 250
A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
Mendell, J. R., Sahenk, Z., Malik, V., Gomez, A. M., Flanigan, K. M., Lowes, L. P., Alfano, L. N., Berry, K., Meadows, E., Lewis, S., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2014.200 · Cited by 246
Campbell, C., McMillan, H. J., Mah, J. K., Tarnopolsky, M., Selby, K., McClure, T., Wilson, D. M., Sherman, M. L., Escolar, D., & Attie, K. M. (2017) · Muscle & Nerve · doi:10.1002/mus.25268 · Cited by 240
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis
Sugimoto, H., LeBleu, V. S., Bosukonda, D., Keck, P., Taduri, G., Bechtel, W., Okada, H., Carlson, W., Bey, P., Rusckowski, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2629 · Cited by 231
Evaluation of Anti-TGF-β2 Antibody as a New Postoperative Anti-scarring Agent in Glaucoma Surgery
Mead, A. L., Wong, T. T. L., Cordeiro, M. F., Anderson, I. K., & Khaw, P. T. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0978 · Cited by 225
Taipale, J., Saharinen, J., Hedman, K., & Keski-Oja, J. (1996) · Journal of Histochemistry & Cytochemistry · doi:10.1177/44.8.8756760 · Cited by 224
Petersen, M., Thorikay, M., Deckers, M., van Dinther, M., Grygielko, E. T., Gellibert, F., de Gouville, A. C., Huet, S., ten Dijke, P., & Laping, N. J. (2008) · Kidney International · doi:10.1038/sj.ki.5002717 · Cited by 215
CTGF expression in mesangial cells: Involvement of SMADs, MAP kinase, and PKC
Chen, Y., Blom, I. E., Sa, S., Goldschmeding, R., Abraham, D. J., & Leask, A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00567.x · Cited by 210
Elevated expression of activins promotes muscle wasting and cachexia
Chen, J. L., Walton, K. L., Winbanks, C. E., Murphy, K. T., Thomson, R. E., Makanji, Y., Qian, H., Lynch, G. S., Harrison, C. A., & Gregorevic, P. (2014) · The FASEB Journal · doi:10.1096/fj.13-245894 · Cited by 202
Self-citationGrygielko, E. T., Martin, W. M., Tweed, C., Thornton, P., Harling, J., Brooks, D. P., & Laping, N. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082099 · Cited by 190
Popov, Y., Patsenker, E., Stickel, F., Zaks, J., Bhaskar, K. R., Niedobitek, G., Kolb, A., Friess, H., & Schuppan, D. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.021 · Cited by 185
Smad3/AP-1 interactions control transcriptional responses to TGF-β in a promoter-specific manner
Verrecchia, F., Vindevoghel, L., Lechleider, R. J., Uitto, J., Roberts, A. B., & Mauviel, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204448 · Cited by 183
Elevated Levels of Activin A in Heart Failure: Potential Role in Myocardial Remodeling
Yndestad, A., Ueland, T., Øie, E., Florholmen, G., Halvorsen, B., Attramadal, H., Simonsen, S., Frøland, S. S., Gullestad, L., Christensen, G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000120704.97934.41 · Cited by 180
BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells
Wang, S., & Hirschberg, R. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00382.2002 · Cited by 177
A single ascending‐dose study of muscle regulator ace‐031 in healthy volunteers
Attie, K. M., Borgstein, N. G., Yang, Y., Condon, C. H., Wilson, D. M., Pearsall, A. E., Kumar, R., Willins, D. A., Seehra, J. S., & Sherman, M. L. (2013) · Muscle & Nerve · doi:10.1002/mus.23539 · Cited by 176
Santiago, B., Gutierrez-Cañas, I., Dotor, J., Palao, G., Lasarte, J. J., Ruiz, J., Prieto, J., Borrás-Cuesta, F., & Pablos, J. L. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23859.x · Cited by 171
The role of TGF‐β1 during skeletal muscle regeneration
Delaney, K., Kasprzycka, P., Ciemerych, M. A., & Zimowska, M. (2017) · Cell Biology International · doi:10.1002/cbin.10725 · Cited by 168
Qiao, C., Li, J., Jiang, J., Zhu, X., Wang, B., Li, J., & Xiao, X. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.159 · Cited by 163
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4
Jiang, D., Liang, J., Campanella, G. S., Guo, R., Yu, S., Xie, T., Liu, N., Jung, Y., Homer, R., Meltzer, E. B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38644 · Cited by 159
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Breitkopf‐Heinlein, K., Meyer, C., König, C., Gaitantzi, H., Addante, A., Thomas, M., Wiercinska, E., Cai, C., Li, Q., Wan, F., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313314 · Cited by 154
Böttinger, E. P., Factor, V. M., Tsang, M., Weatherbee, J. A., Kopp, J. B., Qian, S. W., Wakefield, L. M., Roberts, A. B., Thorgeirsson, S. S., & Sporn, M. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5877 · Cited by 153
Occleston, N. L., Laverty, H., O’Kane, S., & Ferguson, M. W. J. (2008) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208784909345 · Cited by 146
Activin A Is a Potent Activator of Renal Interstitial Fibroblasts
Yamashita, S., Maeshima, A., Kojima, I., & Nojima, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000103225.68136.e6 · Cited by 141
The Role of TGF-β2 and Bone Morphogenetic Proteins in the Trabecular Meshwork and Glaucoma
Wordinger, R. J., Sharma, T. P., & Clark, A. F. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0220 · Cited by 139
Sun, B., Huo, R., Sheng, Y., Li, Y., Xie, X., Chen, C., Liu, H., Li, N., Li, C., Guo, W., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.00562 · Cited by 131
Transforming growth factor-β1 and fibrosis in congenital muscular dystrophies
Bernasconi, P., Blasi, C. D., Mora, M., Morandi, L. O., Galbiati, S., Confalonieri, P. A., Cornelio, F., & Mantegazza, R. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(98)00093-5 · Cited by 126
Effects of myostatin deletion in aging mice
Morissette, M. R., Stricker, J., Rosenberg, M. A., Buranasombati, C., Levitan, E. B., Mittleman, M. A., & Rosenzweig, A. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00508.x · Cited by 125
Zhang, L. P., Takahara, T., Yata, Y., Furui, K., Jin, B., Kawada, N., & Watanabe, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80351-1 · Cited by 124
Harrison, C. A., Al-Musawi, S. L., & Walton, K. L. (2011) · Growth Factors · doi:10.3109/08977194.2011.608666 · Cited by 124
Self-citationChen, J. L., Walton, K. L., Hagg, A., Colgan, T. D., Johnson, K., Qian, H., Gregorevic, P., & Harrison, C. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620013114 · Cited by 116
Self-citationStructural basis for potency differences between GDF8 and GDF11
Walker, R. G., Czepnik, M., Goebel, E. J., McCoy, J. C., Vujić, A., Cho, M., Oh, J., Aykul, S., Walton, K. L., Schang, G., et al. (2017) · BMC Biology · doi:10.1186/s12915-017-0350-1 · Cited by 116
Self-citationFollistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes
Mendell, J. R., Sahenk, Z., Al-Zaidy, S. A., Rodino‐Klapac, L. R., Lowes, L. P., Alfano, L. N., Berry, K., Miller, N. F., YALVAÇ, M. E., Dvorchik, I., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.02.015 · Cited by 113
Patella, S., Phillips, D. J., Tchongue, J., de Kretser, D. M., & Sievert, W. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00080.2005 · Cited by 110
Attenuation of Bleomycin-induced Pulmonary Fibrosis by Follistatin
Aoki, F., Kurabayashi, M., Hasegawa, Y., & Kojima, I. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1620oc · Cited by 108
Immunohistochemical detection of transforming growth factor-β1 in fibrotic liver diseases
Nagy, P., Schaff, Z., & Lapis, K. (1991) · Hepatology · doi:10.1002/hep.1840140211 · Cited by 107
Hermida, N., López, B., González, A., Dotor, J., Lasarte, J. J., Sarobe, P., Borrás‐Cuesta, F., & Dı́ez, J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn315 · Cited by 107
Terada, Y., Hanada, S., Nakao, A., Kuwahara, M., Sasaki, S., & Marumo, F. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.0610s1094.x · Cited by 101
Activin A induces cell proliferation of fibroblast‐like synoviocytes in rheumatoid arthritis
Ota, F., Maeshima, A., Yamashita, S., Ikeuchi, H., Kaneko, Y., Kuroiwa, T., Hiromura, K., Ueki, K., Kojima, I., & Nojima, Y. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11249 · Cited by 95
Effects of Activin A on Proliferation and Differentiation of Human Lung Fibroblasts
Ohga, E., Matsuse, T., Teramoto, S., Katayama, H., Nagase, T., Fukuchi, Y., & Ouchi, Y. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1672 · Cited by 92
BMP-7 as antagonist of organ fibrosis
Weiskirchen, R. (2009) · Frontiers in bioscience · doi:10.2741/3583 · Cited by 90
Expression of activin A is increased in cirrhotic and fibrotic rat livers
Sugiyama, M., Ichida, T., Sato, T., Ishikawa, T., Matsuda, Y., & Asakura, H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70539-6 · Cited by 88
Interleukin-6, its role in fibrosing conditions
O’Reilly, S., Ciechomska, M., Cant, R., Hügle, T., & van Laar, J. M. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.003 · Cited by 87
Agapova, O. A., Fang, Y., Sugatani, T., Seifert, M. E., & Hruska, K. A. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.002 · Cited by 83
Role of bone morphogenetic protein-7 in renal fibrosis
Li, R. X., Yiu, W. H., & Tang, S. C. W. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00114 · Cited by 80
Wohl, A. P., Troilo, H., Collins, R. F., Baldock, C., & Sengle, G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.704734 · Cited by 80
Hamrick, M. W., Arounleut, P., Kellum, E., Cain, M. A., Immel, D., & Liang, L. (2010) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181c451f4 · Cited by 78
Muñoz‐Félix, J. M., González-Núñez, M., Martínez‐Salgado, C., & López-Novoa, J. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.003 · Cited by 78
Yang, Y., Liu, Y., Chuang, L., Guh, J., Lee, T., Liao, T., Hung, M., & Chiang, T. (2008) · Endocrinology · doi:10.1210/en.2008-0090 · Cited by 72
Westergren‐Thorsson, G., Hedström, U., Nybom, A., Tykesson, E., Åhrman, E., Hornfelt, M., Maccarana, M., Kuppevelt, T. H. V., Dellgren, G., Wildt, M., et al. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.12.005 · Cited by 70
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Arndt, S., Wacker, E., Dorn, C., Koch, A., Saugspier, M., Thasler, W. E., Hartmann, A., Bosserhoff, A., & Hellerbrand, C. (2014) · Gut · doi:10.1136/gutjnl-2014-306968 · Cited by 68
Murine Preosteoblast Differentiation Induced by a Peptide Derived from Bone Morphogenetic Proteins-9
Bergeron, E., Senta, H., Mailloux, A., Park, H., Lord, É., & Faucheux, N. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0189 · Cited by 67
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity
Masola, V., Zaza, G., Secchi, M. F., Gambaro, G., Lupo, A., & Onisto, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.06.005 · Cited by 67
Smad and p38 MAP Kinase-mediated Signaling of Proteoglycan Synthesis in Vascular Smooth Muscle
Dadlani, H., Ballinger, M. L., Osman, N., Getachew, R., & Little, P. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m703125200 · Cited by 66
Goumenos, D. S., Tsamandas, A. C., Oldroyd, S., Sotsiou, F., Tsakas, S., Petropoulou, C., Bonikos, D. S., Nahas, A. M. E., & Vlachojannis, J. G. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000045921 · Cited by 65
BMP-7 counteracting TGF-beta1 activities in organ fibrosis
Weiskirchen, R. (2013) · Frontiers in bioscience · doi:10.2741/4189 · Cited by 65
Activin A Binds to Perlecan through Its Pro-region That Has Heparin/Heparan Sulfate Binding Activity
Li, S., Shimono, C., Norioka, N., Nakano, I., Okubo, T., Yagi, Y., Hayashi, M., Sato, Y., Fujisaki, H., Hattori, S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177865 · Cited by 65
Heparan Sulfate Proteoglycan Expression in Chronic Cholestatic Human Liver Diseases
Roskams, T., Rosenbaum, J., Vos, R. D., David, G., & Desmet, V. (1996) · Hepatology · doi:10.1002/hep.510240310 · Cited by 61
Loss of Endogenous Bone Morphogenetic Protein-6 Aggravates Renal Fibrosis
Dendooven, A., van Oostrom, O., van der Giezen, D. M., Leeuwis, J. W., Snijckers, C. M. J. T., Joles, J. A., Robertson, E. J., Verhaar, M. C., Nguyen, T. Q., & Goldschmeding, R. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.005 · Cited by 61
Urbina, P., & Singla, D. K. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00367.2014 · Cited by 61
Álvarez, K., Fadić, R., & Brandan, E. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10184 · Cited by 61
Peptide inhibitors of transforming growth factor‐β enhance the efficacy of antitumor immunotherapy
Llópiz, D., Dotor, J., Casares, N., Bezunartea, J., Díaz‐Valdés, N., Ruiz, M., Aranda, F., Berraondo, P., Prìeto, J., Lasarte, J. J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24656 · Cited by 59
The Genetic and Environmental Causes of Pulmonary Fibrosis
Macneal, K., & Schwartz, D. A. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201112-055aw · Cited by 59
Myostatin induces interstitial fibrosis in the heart via TAK1 and p38
Biesemann, N., Mendler, L., Sawa Kostin, D., Wietelmann, A., Borchardt, T., & Braun, T. W. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2139-2 · Cited by 58
Pirfenidone treatment of idiopathic pulmonary fibrosis
Azuma, A. (2012) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465812436663 · Cited by 58
Transforming Growth Factor‐β as a Regulator of Site‐Specific T‐Cell Inflammatory Response
Ludviksson, B. R., & Gunnlaugsdóttir, B. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01297.x · Cited by 56
Bone morphogenetic protein-7 inhibits silica-induced pulmonary fibrosis in rats
Yang, G., Zhu, Z., Wang, Y., Gao, A., Niu, P., & Tian, L. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.04.017 · Cited by 56
Development of Novel Activin-Targeted Therapeutics
Chen, J. L., Walton, K. L., Al-Musawi, S. L., Kelly, E. K., Qian, H., La, M., Lu, L., Lovrecz, G. O., Ziemann, M., Lazarus, R. M., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.221 · Cited by 56
Self-citationBergeron, E., Leblanc, E., Drevelle, O., Giguère, R., Beauvais, S., Grenier, G., & Faucheux, N. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0008 · Cited by 51
Potential Roles of BMP9 in Liver Fibrosis
Bi, J., & Ge, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120656 · Cited by 46
Expression and characterization of a human BMP-7 variant with improved biochemical properties
Swencki‐Underwood, B., Mills, J. K., Vennarini, J., Boakye, K., Luo, J., Pomerantz, S. C., Cunningham, M. R., Farrell, F. X., Naso, M. F., & Amegadzie, B. Y. (2007) · Protein Expression and Purification · doi:10.1016/j.pep.2007.09.016 · Cited by 43
Enhanced Bioactive Myocardial Transforming Growth Factor-β in Advanced Human Heart Failure
Khan, S. A., Joyce, J., Margulies, K. B., & Tsuda, T. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0511 · Cited by 42
Myostatin Stimulates, Not Inihibits, C2C12 Myoblast Proliferation
Rodgers, B. D., Wiedeback, B. D., Hoversten, K. E., Jackson, M. F., Walker, R. G., & Thompson, T. B. (2014) · Endocrinology · doi:10.1210/en.2013-2107 · Cited by 41
de Kretser, D. M., Bensley, J. G., Pettilä, V., Linko, R., Hedger, M. P., Hayward, S., Allan, C. A., McLachlan, R. I., Ludlow, H., & Phillips, D. J. (2013) · Critical Care · doi:10.1186/cc13093 · Cited by 39
Role of Glomerular Proteoglycans in IgA Nephropathy
Ebefors, K., Granqvist, A., Ingelsten, M., Mölne, J., Haraldsson, B. S., & Nystrom, J. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018575 · Cited by 36
Murakami, M., Ikeda, T., Saito, T., Ogawa, K., Nishino, Y., Nakaya, K., & Funaba, M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.010 · Cited by 33
The activin A antagonist follistatin inhibits cystic fibrosis‐like lung inflammation and pathology
Hardy, C. L., King, S., Mifsud, N. A., Hedger, M. P., Phillips, D. J., Mackay, F., de Kretser, D. M., Wilson, J. W., Rolland, J. M., & O’Hehir, R. E. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.7 · Cited by 32
BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor.
Wang, L., Dong, J., Xiong, L., Shi, K., Zou, Z., Zhang, S., Cao, S.-T., Lin, Z., & Chen, Y. (2014) · PubMed Central · Cited by 31
Yamada, M., Kuwano, K., Maeyama, T., et al. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.039396 · Cited by 31
Zhang, Y., Liu, P., Gao, X., Qian, W., & Xu, K. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1119-3 · Cited by 28
Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro
Muñoz‐Félix, J. M., Cuesta, C., Perretta‐Tejedor, N., Subileau, M., López-Hernández, F. J., López-Novoa, J. M., & Martínez‐Salgado, C. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.05.015 · Cited by 26
Interleukin-1 in renal fibrosis.
Nikolic‐Paterson, D. J., Iw, M., Tesch, G. H., Lan, H. Y., & Atkins, R. C. (1996) · PubMed · Cited by 26
Molina‐Molina, M., Lario, S., Luburich, P., Ramírez, J., Carrión, M. T., & Xaubet, A. (2006) · Archivos de Bronconeumología · doi:10.1157/13091645 · Cited by 25
Denholm, E. M., & Rollins, S. M. (1993) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1993.264.1.l36 · Cited by 23
Quantifying Plasma Levels of Transforming Growth Factor β1 in Idiopathic Pulmonary Fibrosis
Molina‐Molina, M., Lario, S., Luburich, P., Ramírez, J., Carrión, M. T., & Xaubet, A. (2006) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(06)60550-8 · Cited by 20
The advancements of heparanase in fibrosis.
Lv, Q., Zeng, J., & He, L. (2016) · PubMed Central · Cited by 12
Cited by
New insights into TGF-β/Smad signaling in tissue fibrosis
Hu, H.-H., Chen, D.-Q., Wang, Y.-N., Feng, Y.-L., Cao, G., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.008 · Cited by 1,179
Skeletal muscle fibrosis: an overview
Mahdy, M. A. A. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-2955-2 · Cited by 363
TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
Pardali, E., Sanchez-Duffhues, G., Gomez-Puerto, M., & Ten Dijke, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102157 · Cited by 360
Chen, L., Yang, T., Lu, D.-W., Zhao, H., Feng, Y.-L., Chen, H., Chen, D.-Q., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.090 · Cited by 359
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
Phan, T. H. G., Paliogiannis, P., Nasrallah, G. K., Giordo, R., Eid, A. H., Fois, A. G., Zinellu, A., Mangoni, A. A., & Pintus, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03693-7 · Cited by 351
Metadata
- Authors
- Walton, K. L., Johnson, K. E., & Harrison, C. A.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-07-14
- Volume
- 8
- Pages
- 461-461
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2735790845
- Cited by
- 543
- References
- 120
- FWCI
- 13.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.